QA: AYTU Biopharma INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385818_2025_AYTU_Biopharma_INC.pdf

Logs

Graph

Absolute values for 0001385818, AYTU Biopharma INC

  xvar xval
0 AssetsCurrent 61,891,000
1 IntangibleAssetsNetIncludingGoodwill 52,453,000
2 PropertyPlantAndEquipmentNet 693,000
3 remainder_Assets 3,058,000
4 LiabilitiesCurrent 62,228,000
5 LiabilitiesNoncurrent 28,151,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold -8,090,282
8 SellingGeneralAndAdministrativeExpense 9,853,737
9 ResearchAndDevelopmentExpense 2,962,739
10 remainder_Expenses 34,188,840
11 remainder_Revenues -3,268,378
12 remainder_NetIncome -593,484
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 118,095,000
1 Liabilities 90,379,000
2 Expenses 38,915,034
3 Revenues -3,268,378
4 StockholdersEquity 27,716,000
5 NetIncome -42,776,896
6 ComprehensiveNetIncome -42,776,896
7 BaseVar 125,625,448
8 EconomicCapitalRatiobeforeLimitedLiability 0.169
9 EconomicCapitalRatio 1.58

Edgar->Model Mapping

Feature Distribution

Change over Time